Spironolactone Therapy in Chronic Stable Right HF Trial
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and mechanistic effects of
spironolactone, an aldosterone receptor antagonist, on sympathetic nervous system activity
and right heart function and remodeling in patients with chronic right heart failure.